Oral Androgens in Man-4: (Short Title: Oral T-4)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Contraception
Interventions
DRUG

Testosterone Enanthate

Oral Testosterone 400 mg orally for 28 days

DRUG

Testosterone Enanthate

Oral Testosterone 800 mg orally for 28 days

DRUG

Dutasteride

dutasteride 0.5 mg orally, once daily for 28 days

OTHER

placebo sesame oil

placebo sesame oil

DRUG

Dutasteride

24.5 mg po once (Day 0)

Trial Locations (1)

98195

University of Washington, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Washington

OTHER